Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 102 (1) , 109-118
- https://doi.org/10.1016/0016-5085(92)91790-b
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Double-blind Comparative Study of Omeprazole, 40 mg Once DailyvsCimetidine, 400 mg q.d.s., in the Treatment of Erosive Reflux OesophagitisScandinavian Journal of Gastroenterology, 1989
- Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitisDigestive Diseases and Sciences, 1988
- Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trialBMJ, 1988
- Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.Gut, 1984
- Effect of daily oral omeprazole on 24 hour intragastric acidity.BMJ, 1983
- Mechanisms of Gastroesophageal Reflux in Patients with Reflux EsophagitisNew England Journal of Medicine, 1982
- Acid clearance during sleep in the pathogenesis of reflux esophagitisDigestive Diseases and Sciences, 1981
- Symptomatic gastroesophageal reflux: Incidence and precipitating factorsDigestive Diseases and Sciences, 1976
- Patterns of Gastroesophageal Reflux in Health and DiseaseAnnals of Surgery, 1976
- Oesophageal acid clearing: One factor in the production of reflux oesophagitisGut, 1974